|
|
| Catalog Number |
D138402 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Burn(s) (1757)
|
| Date of Event |
07/19/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient underwent an atrial fibrillation ablation and the patient experienced skin burns that required bandages.The procedure occurred on (b)(6) 2024.After the procedure was completed, the patient was moved to the recovery area.While in the recovery area, it was noticed that the patient received a burn where the ablation grounding pads were placed.Unaware of any medical interventions that were provided to the patient.The patient was believed to be in stable condition.Bandage was applied to area post care.Patient fully recovered and did not require extended hospitalization.The physician's opinion on the cause of the adverse event is that the burn was caused by one of the patches on patient crumpling up on skin.
|
| |
|
Additional Manufacturer Narrative
|
|
D4: udi: the manufacturing date is currently not available.Therefore, the full udi is currently not available.The hardware investigation has begun but it has not been completed at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Per internal review on 13-dec-2024, a typographical error was identified on section d2 where the procode was mistakenly submitted as "lbp".The correction is that the d2 procode is "lpb" to represent " cardiac ablation percutaneous catheter".If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On 30-sep-2024, the product investigation was completed.As the manufacture date was identified, the d4 primary udi number has been updated to (b)(4).On that date (30-sep-2024), it was also identified that a clarifying information was mistakenly omitted from the h11 additional manufacturer narrative section, which goes as follows: per fda request, mdr submissions for the ngen rf generator are to be reported with pma details of the catheter used along with the ngen rf generator.However, the catheter used in this case is currently unknown, therefore no pma details are available.Follow-up was performed and no additional information was provided.Therefore, this file is processed with the ablation catheter information of the smart touch sf.Device evaluation details: it was reported that a patient underwent an atrial fibrillation ablation and the patient experienced skin burns that required bandages.The procedure occurred on (b)(6) 2024.After the procedure was completed, the patient was moved to the recovery area.While in the recovery area, it was noticed that the patient received a burn where the ablation grounding pads were placed.Unaware of any medical interventions that were provided to the patient.The patient was believed to be in stable condition.Bandage was applied to area post care.Patient fully recovered and did not require extended hospitalization.The unit was analyzed by technical services, following their procedures.They concluded that no failure was found on the unit.A device history record evaluation was performed for the finished device number 23450074fg, and no internal actions related to the reported condition were identified.Johnson & johnson medtech's quality process ensures all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|